Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design

被引：0
|
作者：
Min Wu
Cuiyun Li
Hong Zhang
Jixuan Sun
Xiaoxue Zhu
Xiaojiao Li
Xuedong Gao
Wei Wang
Yanhua Ding
机构：
[1] The First Hospital of Jilin University,Department of Phase I Clinical Trial Unit
[2] Shijiazhuang Yiling Pharmaceutical Co.,undefined
[3] Ltd,undefined
来源：
CNS Drugs | 2020年 / 34卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：867 / 877
页数：10
相关论文
共 50 条
  • [21] A First-In-Human, Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ketamine in Healthy Volunteers
    Silman, Daniel
    Gadelrab, Romayne
    Qureshi, Mutahira
    Stein, Hans
    Mehta, Mitul
    Carmelline, Pietro
    Young, Allan
    Reilly, Carmel
    Duncan, Graeme
    Juruena, Mario
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 155 - 155
  • [22] A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in healthy volunteers
    Moench, Thomas R.
    Botta, Lakshmi
    Farrer, Brian
    Lickliter, Jason D.
    Kang, Hyunah
    Park, Yoona
    Kim, Cheolmin
    Hoke, Marshall
    Brennan, Miles
    Mcsweeney, Morgan D.
    Richardson, Zachary
    Whelan, John B.
    Cho, Jong Moon
    Lee, Soo Young
    Faurot, Frances
    Hutchins, Jeff
    Lai, Samuel K.
    EBIOMEDICINE, 2025, 113
  • [23] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
    Li, Yi
    Toyama, Kaoru
    Nakatsu, Takafumi
    Ishizuka, Hitoshi
    Wu, Hailan
    Cao, Guoying
    Yu, Jicheng
    Wang, Yu
    Liu, Xiaofen
    Guo, Beining
    Wu, Jufang
    Yu, Peimin
    Hong, Zhen
    Zhang, Jing
    Wu, Xiaojie
    ADVANCES IN THERAPY, 2023, 40 (04) : 1628 - 1643
  • [24] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
    Yi Li
    Kaoru Toyama
    Takafumi Nakatsu
    Hitoshi Ishizuka
    Hailan Wu
    Guoying Cao
    Jicheng Yu
    Yu Wang
    Xiaofen Liu
    Beining Guo
    Jufang Wu
    Peimin Yu
    Zhen Hong
    Jing Zhang
    Xiaojie Wu
    Advances in Therapy, 2023, 40 (4) : 1628 - 1643
  • [25] The Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Ebronucimab in Healthy Volunteers: Result From a Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Dose-Escalation Study
    Chen, Rui
    Tian, Zhuang
    Tang, Xiange
    Hu, Pei
    Wang, Lvya
    Xia, Yu
    Li, Baiyong
    Wang, Max
    Ni, Xiang
    Wang, Guoqin
    Zhang, Shuyang
    CIRCULATION, 2022, 146
  • [26] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of the Safety, Tolerability and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Camilo, Juan
    Ferreira, Arjona
    GASTROENTEROLOGY, 2016, 150 (04) : S537 - S538
  • [27] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Ferreira, Juan Camilo Arjona
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483
  • [28] Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administration
    Yu, Yimin
    He, Jingjing
    Huang, Zhiwei
    Li, Yan
    Wu, Ying
    Shen, Yifeng
    Zhou, Yanling
    Bao, Cungang
    Jin, Zhiping
    Li, Huafang
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (01) : 51 - 61
  • [29] A Randomized, Double-Blind, Multiple-Dose, Placebo-Controlled, Dose Escalation Study With a 3-Cohort Parallel Group Design to Investigate the Tolerability and Pharmacokinetics of Albaconazole in Healthy Subjects
    Dietz, Albert J.
    Barnard, Joanna C.
    van Rossem, Koen
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (01): : 25 - 33
  • [30] Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase I study
    Huang, Kai
    Ding, Ying
    Que, Linling
    Chu, Nannan
    Shi, Yunfei
    Qian, Zhenzhong
    Qin, Wei
    Chen, Yuanxin
    Gu, Xianghong
    Wang, Jiakun
    Zhang, Zhiwei
    Xu, Jianguo
    He, Qing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345